Call for Your FREE Evaluation (877) 503-1595

FDA Rejects a New Use for Xarelto

Areas of Practice

Get a FREE Evaluation

By submitting this form you agree to be contacted by KirkendallDwyer.com affiliates and/or attorneys regarding your claim. You consent to KirkendallDwyer.com contacting you through the use of text message, phone call, and electronic mail message even if your number is a wireless number or if I am presently listed on a Do Not Call list. My consent does not require purchase.

Call for your FREE consultation with a personal attorney: (877) 503-1595

Warafin

FDA Rejects a New Use for Xarelto

Xarelto, an alternative to warfarin, the traditional treatment for atrial fibrillation, has suffered another rejection by the FDA. This is the second time that Johnson & Johnson has tried to get Xarelto approved to treat acute coronary syndrome, and the second time the FDA has refused to do so.

Posted in Pharmaceutical and Medical Device News,
Tagged Pradaxa, FDA, Drug Safety, Pradaxa Attorney, Warafin, Xarelto,